1)日本食道学会(編);食道癌診療ガイドライン,2017年版.金原出版,2017,pp 78-85
2)天沼祐介,堀松高博,大橋真也,他:薬事承認後の食道癌に対するレザフィリンPDTの臨床成績.日レ医誌40:57-61,2019
3)Yano T, Muto M, Hattori S, et al:Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 43:657-663, 2011
4)Hatogai K, Yano T, Kojima T, et al:Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Gastrointest Endosc 83:1130-1139, 2016
5)Wang S, Tachimori Y, Hokamura N, et al:Prognostic analysis of salvage esophagectomy after definitive chemoradiotherapy for esophageal squamous cell carcinoma:the importance of lymphadenectomy. J Thorac Cardiovasc Surg 147:1805-1811, 2014
6)Takeuchi H, Saikawa Y, Oyama T, et al:Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg 34:277-284, 2010
7)Tachimori Y, Kanamori N, Uemura N,et al:Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137:49-54, 2009
8)亀井 尚,宮崎修吉,宮田 剛,他:食道癌化学放射線療法後のsalvage手術の意義と適応.癌の臨53:647-655,2007
9)東野晃治,福田弘武,嶋本有策,他:PDT後遺残再発食道癌に対する再PDTの有効性についての検討.日レ医誌40:77-81,2019
10)大森隼人,竹林克士,坊岡英祐,他:光線力学療法後の局所遺残再発に対して食道切除を行った食道癌の2例.日臨外会誌77:1964-1969,2016
11)Horimatsu T, Muto M, Yoda Y, et al:Tissue damage in the canine normal esophagus by photoactivation with talaporfin sodium(laserphyrin):a preclinical study. PLoS ONE 7:e38308, 2012